Skip to content

Synoviomics II: Advanced genomics intitiative in different phases of arthritis

Synoviomics II: Advanced genomics intitiative in different phases of arthritis - Synoviomics II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31664
Enrollment
1500
Registered
2008-04-17
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory joint diseases

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: active inflammation of at least one joint

Exclusion criteria

Exclusion criteria: When in the opinion of the responsible investigator it is not in the interest of the patient to be enrolled (eg for safety reasons or severe co-morbidity).

Design outcomes

Primary

MeasureTime frame
none, observational study

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)